Back

Fatty acid-induced lipotoxicity inhibits choline metabolism independent of ER stress in mouse primary hepatocytes

O'Dwyer, C.; Yaworski, R.; LeBlond, N. D.; Ghorbani, P.; Nunes, J. R.; Margison, K. D.; Smith, T. T.; Gobeil Odai, K.; Han, S.; Fullerton, M. D.

2019-08-25 cell biology
10.1101/746750 bioRxiv
Show abstract

Choline is an essential nutrient that is critical component of the membrane phospholipid phosphatidylcholine (PC), the neurotransmitter acetylcholine and the methylation pathway. In the liver specifically, PC is the major membrane constituent and can be synthesized by the CDP-choline or the phosphatidylethanolamine (PE) N-methyltransferase (PEMT) pathway. With the continuing global rise in the rates of obesity and non-alcoholic fatty liver disease, we sought to explore how excess fatty acids (FA), typical of an obesity and hepatic steatosis, affect choline uptake and metabolism in primary hepatocytes. Our results demonstrate that hepatocytes chronically treated with palmitate, but not oleate or a mixture, had decreased choline uptake, which was associated with lower choline incorporation into PC and lower expression of choline transport proteins. Interestingly, a reduction in the rate of degradation spared PC levels in response to palmitate when compared to control. PE synthesis was slightly diminished; however, no compensatory changes in the PEMT pathway were observed. We next hypothesized that ER stress may be a potential mechanism by which palmitate treatment diminished choline. However, when we exposed primary hepatocytes to the common ER stress inducing compound tunicamycin, choline uptake, contrary to our expectation was augmented, concomitant with the transcript expression of choline transporters. Moreover, tunicamycin-induced ER stress divorced the observed increase in choline uptake from CDP-choline pathway flux since ER stress significantly diminished the incorporation and total PC content, similar to PE. Conclusion: Therefore, our results suggest that the altered FA milieu seen in obesity and fatty liver disease progression may adversely affect choline metabolism, but that compensatory mechanisms work to maintain phospholipid homeostasis.\n\n\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=175 SRC=\"FIGDIR/small/746750v1_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (42K):\norg.highwire.dtl.DTLVardef@1090f2aorg.highwire.dtl.DTLVardef@1c28eedorg.highwire.dtl.DTLVardef@35a80eorg.highwire.dtl.DTLVardef@ac5a53_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Journal of Lipid Research
39 papers in training set
Top 0.1%
58.0%
50% of probability mass above
2
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
15 papers in training set
Top 0.1%
13.5%
3
Journal of Biological Chemistry
690 papers in training set
Top 2%
5.7%
4
The FASEB Journal
194 papers in training set
Top 1%
2.8%
5
eLife
5828 papers in training set
Top 54%
1.4%
6
Molecular Metabolism
112 papers in training set
Top 1%
1.2%
7
International Journal of Molecular Sciences
494 papers in training set
Top 12%
1.1%
8
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 4%
0.9%
9
PLOS ONE
5266 papers in training set
Top 60%
0.9%
10
Metabolites
53 papers in training set
Top 0.8%
0.9%
11
American Journal of Physiology-Endocrinology and Metabolism
36 papers in training set
Top 0.5%
0.9%
12
JHEP Reports
11 papers in training set
Top 0.3%
0.6%
13
American Journal of Physiology-Cell Physiology
39 papers in training set
Top 0.9%
0.6%
14
Toxicology and Applied Pharmacology
14 papers in training set
Top 0.3%
0.6%
15
Hepatology Communications
22 papers in training set
Top 0.4%
0.6%
16
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 43%
0.6%
17
The American Journal of Pathology
32 papers in training set
Top 1.0%
0.5%
18
Nature Communications
5641 papers in training set
Top 61%
0.5%
19
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.4%
0.5%
20
The Journal of Nutrition
25 papers in training set
Top 0.7%
0.5%
21
Molecular Oncology
55 papers in training set
Top 2%
0.5%
22
Pediatric Research
21 papers in training set
Top 0.5%
0.5%
23
Scientific Reports
3612 papers in training set
Top 81%
0.5%
24
Function
14 papers in training set
Top 0.3%
0.5%